AU4794393A - Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv - Google Patents
Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase ivInfo
- Publication number
- AU4794393A AU4794393A AU47943/93A AU4794393A AU4794393A AU 4794393 A AU4794393 A AU 4794393A AU 47943/93 A AU47943/93 A AU 47943/93A AU 4794393 A AU4794393 A AU 4794393A AU 4794393 A AU4794393 A AU 4794393A
- Authority
- AU
- Australia
- Prior art keywords
- hematopoietic cells
- dipeptidyl peptidase
- increased numbers
- producing increased
- administering inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 title 1
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 title 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92333792A | 1992-07-31 | 1992-07-31 | |
US923337 | 1992-07-31 | ||
PCT/US1993/007173 WO1994003055A1 (en) | 1992-07-31 | 1993-07-30 | Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4794393A true AU4794393A (en) | 1994-03-03 |
Family
ID=25448524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47943/93A Abandoned AU4794393A (en) | 1992-07-31 | 1993-07-30 | Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4794393A (en) |
WO (1) | WO1994003055A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6825169B1 (en) | 1991-10-22 | 2004-11-30 | Trustees Of Tufts College | Inhibitors of dipeptidyl-aminopeptidase type IV |
US5965532A (en) | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
EP0834556A1 (en) * | 1996-09-25 | 1998-04-08 | Academisch Ziekenhuis Leiden | Methods for culturing cells |
US6040145A (en) * | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
US6100234A (en) * | 1997-05-07 | 2000-08-08 | Tufts University | Treatment of HIV |
AU778608B2 (en) * | 1997-09-29 | 2004-12-16 | Point Therapeutics, Inc. | Stimulation of hematopoietic cells in vitro |
ES2285785T3 (en) * | 1997-09-29 | 2007-11-16 | Point Therapeutics, Inc. | STIMULATION OF IN VITRO HEMATOPOYETIC CELLS. |
CA2310400C (en) | 1997-11-18 | 2008-02-19 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Novel physiologically active substance sulphostin, process for producing the same, and use thereof |
AU770319C (en) * | 1998-05-04 | 2004-11-25 | Point Therapeutics, Inc. | Hematopoietic stimulation |
ES2189423T3 (en) | 1998-06-05 | 2003-07-01 | Point Therapeutics Inc | BOROPROLINE CYCLING COMPOUNDS. |
US6979697B1 (en) | 1998-08-21 | 2005-12-27 | Point Therapeutics, Inc. | Regulation of substrate activity |
AU5480199A (en) * | 1998-08-21 | 2000-03-14 | Point Therapeutics, Inc. | Regulation of substrate activity |
US6890904B1 (en) | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
WO2002055088A1 (en) | 2001-01-16 | 2002-07-18 | Nippon Kayaku Kabushiki Kaisha | Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents |
DE60322857D1 (en) | 2002-03-25 | 2008-09-25 | Nippon Kayaku Kk | NEW ALPHA-AMINO-N- (DIAMINOPHOSPHINYL) LACTAM DERIVATIVE |
GB0212412D0 (en) * | 2002-05-29 | 2002-07-10 | Novartis Ag | Combination of organic compounds |
AU2007203210B2 (en) * | 2002-05-29 | 2009-10-01 | Novartis Ag | Combination of a DPP IV inhibitor and a cardiovascular compound |
EP1911754B1 (en) | 2003-08-13 | 2013-10-09 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
JP2007505121A (en) | 2003-09-08 | 2007-03-08 | 武田薬品工業株式会社 | Dipeptidyl peptidase inhibitor |
EP2805953B1 (en) | 2004-12-21 | 2016-03-09 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
PL1942898T5 (en) | 2005-09-14 | 2014-10-31 | Takeda Pharmaceuticals Co | Dipeptidyl peptidase inhibitors for treating diabetes |
CA2622642C (en) | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8933201B2 (en) | 2006-06-07 | 2015-01-13 | The Board Of Regents Of The University Of Oklahoma | Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US9115082B2 (en) | 2012-01-18 | 2015-08-25 | Catherine Yang | Dipeptidyl-peptidase-IV inhibitors for treatment of type 2 diabetes complex with hypertension |
-
1993
- 1993-07-30 WO PCT/US1993/007173 patent/WO1994003055A1/en active Application Filing
- 1993-07-30 AU AU47943/93A patent/AU4794393A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994003055A1 (en) | 1994-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4794393A (en) | Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv | |
AU1025588A (en) | Novel peptidase inhibitors | |
AU5288186A (en) | Novel peptidase inhibitors | |
AU543883B2 (en) | Topical hyperboric oxygen chamber medical | |
AU5974290A (en) | Novel peptidase inhibitors | |
AU3888793A (en) | Novel medicament | |
AU2469388A (en) | Renin inhibitors | |
WO1994027587A3 (en) | Sustained antiepileptic therapy | |
AU3105793A (en) | Process for purifying acrylic acid in high purity in the production of acrylic acid | |
AU8101794A (en) | Medication injector | |
CA2130116A1 (en) | Aminoacetylmercaptoacetylamide Derivatives Useful as Inhibitors of Enkephalinase and Ace | |
AU4687193A (en) | Imidazole-containing analogs of distamycin | |
EP1026157A3 (en) | Method for the synthesis of huperzine A and analogs thereof and compounds useful therein | |
AU665287B2 (en) | Prostaglandin combinations in glaucoma therapy | |
AU1308988A (en) | Therapeutic compositions | |
AU1062683A (en) | Oxygen injection nozzle | |
AU7056994A (en) | Process for asymmetric total synthesis of camptothecin | |
AU1306795A (en) | Anticonvulsant pseudofructopyranose sulfamates | |
AP9300561A0 (en) | Antibiotic compounds. | |
AU4686389A (en) | Intermediates in synthesis of optically active aryloxypropanolamines & arylethanolamines | |
AU3422893A (en) | Methods for regulatory lineages of human hematopoietic cells | |
AU590783B2 (en) | Therapeutic agent for treating hematopoietic diseases | |
AU4633893A (en) | Liposomal formulations for administering to cancer patients | |
AU3810093A (en) | Methods of achieving antitumor activity using 16-membered-macrolide-type compounds | |
CA2105888A1 (en) | Use of a direct thrombin inhibitor in the production of a drug presenting a thrombolytic activity |